机构:[1]Beijing Neurosurgical Institute, Beijing Tiantan Hospital, Capital Medical University, Beijing, China研究所北京市神经外科研究所首都医科大学附属天坛医院[2]Beijing Tsinghua Chang Gung Hospital, School of Clinical Medicine, Tsinghua University, Beijing, China[3]Department of Neurosurgery, Wayne State University School of Medicine, Detroit, MI, USA
Background: For the treatment of intracranial aneurysms, the low-profile visualized intraluminal support (LVIS) stent is a new generation of highly visible-braided stent that was recently introduced in China. Here, we report our single-center retrospective experience of safety and efficacy utilizing LVIS for stent-assisted coiling of intracranial aneurysms. Methods: We included 218 patients with intracranial aneurysms consecutively treated with LVIS SR stents at our center in this study. Postoperative and follow-up embolization scores, procedural complications, clinical and angiographic findings at mid-term follow-up, as well as recurrence rate, preoperative and follow-up mRS scores were analyzed. Results: Two hundred and eighteen patients with two hundred and twenty five intracranial aneurysms were enrolled. The locations and distribution were ICA (125, 55.6%), PcomA (47, 20.9%), VA (38, 16.8%), and BA (15, 6.7%). Two hundred and eighteen aneurysms were treated with the stent-assisted coiling and seven patients with LVIS stents alone. Angiographic follow-up was available for 115 (51.1%) aneurysms, 8 (7.0%) of which had recurrences including 7 (6.5%) unruptured aneurysms and 1(14.3%) ruptured aneurysm. The procedural complication rate was 2.75% in total, including distal hemorrhage (1, 0.45%; SAH), ischemic events (5, 2.3%). Conclusions: Our single-center retrospective experience is one of the larger studies to date assessing the LVIS device. Compared with many laser-cut stent studies, the LVIS device had a higher aneurysm complete occlusion rate at follow-up coupled with low complication rates. However, this study was our initial experience with LVIS, larger patient numbers, and longer follow-up will be needed to fully assess the long-term efficacy of LVIS in treating intracranial aneurysms.
基金:
Beijing Municipal Administration of Hospitals Incubating Program [PX2016066]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China [81471167, 81671139, 81220108007]
第一作者机构:[1]Beijing Neurosurgical Institute, Beijing Tiantan Hospital, Capital Medical University, Beijing, China[2]Beijing Tsinghua Chang Gung Hospital, School of Clinical Medicine, Tsinghua University, Beijing, China
通讯作者:
通讯机构:[1]Beijing Neurosurgical Institute, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
推荐引用方式(GB/T 7714):
Su Wei,Zhang Yisen,Chen Junfan,et al.225 intracranial aneurysms treated with the Low-profile Visualized Intraluminal Support (LVIS) stent: a single-center retrospective study[J].NEUROLOGICAL RESEARCH.2018,40(6):445-451.doi:10.1080/01616412.2018.1457608.
APA:
Su, Wei,Zhang, Yisen,Chen, Junfan,Liu, Jian,Rajah, Gary&Yang, Xinjian.(2018).225 intracranial aneurysms treated with the Low-profile Visualized Intraluminal Support (LVIS) stent: a single-center retrospective study.NEUROLOGICAL RESEARCH,40,(6)
MLA:
Su, Wei,et al."225 intracranial aneurysms treated with the Low-profile Visualized Intraluminal Support (LVIS) stent: a single-center retrospective study".NEUROLOGICAL RESEARCH 40..6(2018):445-451